Divalproex Sodium
- Product NDC
- 0615-7532
- 11-digit product format
- 006157532
- Labeler code
- 0615
- Product ID
- 0615-7532_1fbb3a5a-960b-45f5-8fe2-2cea7685617a
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Divalproex Sodium
- Dosage form
- TABLET, DELAYED RELEASE
- Route
- ORAL
- Labeler
- NCS HealthCare of KY, Inc dba Vangard Labs
- Application
- ANDA078182
- Marketing category
- ANDA
- Marketing start
- 2011-01-21
- Marketing end
- 0000-00-00
- Substance
- DIVALPROEX SODIUM
- Active strength
- 250 mg/1
- Pharmacologic classes
- Anti-epileptic Agent [EPC],Decreased Central Nervous System Disorganized Electrical Activity [PE],Mood Stabilizer [EPC]
- NDC exclude flag
- E
- Listing certified through
- 2017-12-31
- Current FDA listing
- Historical FDA.report record
FDA-Initiated Inactive NDC Indexing#
| NDC | Effective | Action | Document | Indexing SPL | Related label |
|---|---|---|---|---|---|
| 0615-7532-30 | 2021-04-27 | C162847 | 48780-1 | 9d75b9d0-9322-f424-e053-dadaa90a57ce | ae57c8ec-8ea5-4829-a170-a69ddd92c22d |
| 0615-7532-31 | 2021-04-27 | C162847 | 48780-1 | 9d75b9d0-9322-f424-e053-dadaa90a57ce | ae57c8ec-8ea5-4829-a170-a69ddd92c22d |
| 0615-7532-39 | 2021-04-27 | C162847 | 48780-1 | 9d75b9d0-9322-f424-e053-dadaa90a57ce | ae57c8ec-8ea5-4829-a170-a69ddd92c22d |
| 0615-7532-30 | 2020-01-31 | C162847 | 48780-1 | 9d75b9d0-9322-f424-e053-dadaa90a57ce | ae57c8ec-8ea5-4829-a170-a69ddd92c22d |
| 0615-7532-31 | 2020-01-31 | C162847 | 48780-1 | 9d75b9d0-9322-f424-e053-dadaa90a57ce | ae57c8ec-8ea5-4829-a170-a69ddd92c22d |
| 0615-7532-39 | 2020-01-31 | C162847 | 48780-1 | 9d75b9d0-9322-f424-e053-dadaa90a57ce | ae57c8ec-8ea5-4829-a170-a69ddd92c22d |